Loading…
LumiThera Inc. entered a definitive merger agreement to acquire Diopsys, Inc., a leader in visual electrophysiology medical devices, making Diopsys a wholly owned subsidiary.
“The acquisition should provide a complementary diagnosis and monitoring platform to LumiThera's leading treatment platform using Photobiomodulation (PBM) for ocular disease and damage.”prnewswire.com
Summarized from public sources; check the original articles before acting on it.